Neoadjuvant triplet chemotherapy enables radiotherapy avoidance in human papillomavirus–associated oropharyngeal cancer: a multicentre Phase II trial
- DOI
- 10.1038/s41416-026-03610-y
- Published
- 2026-09-05
- Container
- British Journal of Cancer
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41416-026-03610-y,
title = {Neoadjuvant triplet chemotherapy enables radiotherapy avoidance in human papillomavirus–associated oropharyngeal cancer: a multicentre Phase II trial},
author = {Tomoya Yokota and Toyonori Tsuzuki and Tetsuro Onitsuka and Akira Iizuka and Yohei Ouchi and Terushige Mori and Kiyoaki Tsukahara and Kenji Hanyu and Takashi Mukaigawa and Torahiko Nakashima and Hideoki Uryu and Go Omura and Hiromu Nakamura and Hirokazu Uemura and Daisuke Nishikawa and Satoshi Kano and Yasuto Akiyama and Tsuyoshi Onoe and Shunsuke Oyamada and Takuhiro Yamaguchi},
year = {2026},
journal = {British Journal of Cancer},
doi = {10.1038/s41416-026-03610-y},
url = {https://doi.org/10.1038/s41416-026-03610-y}
}RIS
TY - JOUR TI - Neoadjuvant triplet chemotherapy enables radiotherapy avoidance in human papillomavirus–associated oropharyngeal cancer: a multicentre Phase II trial AU - Tomoya Yokota AU - Toyonori Tsuzuki AU - Tetsuro Onitsuka AU - Akira Iizuka AU - Yohei Ouchi AU - Terushige Mori AU - Kiyoaki Tsukahara AU - Kenji Hanyu AU - Takashi Mukaigawa AU - Torahiko Nakashima AU - Hideoki Uryu AU - Go Omura AU - Hiromu Nakamura AU - Hirokazu Uemura AU - Daisuke Nishikawa AU - Satoshi Kano AU - Yasuto Akiyama AU - Tsuyoshi Onoe AU - Shunsuke Oyamada AU - Takuhiro Yamaguchi PY - 2026 JO - British Journal of Cancer DO - 10.1038/s41416-026-03610-y UR - https://doi.org/10.1038/s41416-026-03610-y ER -
APA
Yokota, T., Tsuzuki, T., Onitsuka, T., Iizuka, A., Ouchi, Y., Mori, T., Tsukahara, K., Hanyu, K., Mukaigawa, T., Nakashima, T., Uryu, H., Omura, G., Nakamura, H., Uemura, H., Nishikawa, D., Kano, S., Akiyama, Y., Onoe, T., Oyamada, S., & Yamaguchi, T. (2026). Neoadjuvant triplet chemotherapy enables radiotherapy avoidance in human papillomavirus–associated oropharyngeal cancer: a multicentre Phase II trial. British Journal of Cancer. https://doi.org/10.1038/s41416-026-03610-y
Source records
- crossref · retrieved 2026-09-26T02:18:36.014Z